| Q39768881 | 'Energy expenditure genes' or 'energy absorption genes': a new target for the treatment of obesity and Type II diabetes |
| Q28191413 | A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans |
| Q44071064 | A genome scan among Nigerians linking resting energy expenditure to chromosome 16. |
| Q54683666 | Activation of UCPs gene expression in skeletal muscle can be independent on both circulating fatty acids and food intake. Involvement of ROS in a model of mouse cancer cachexia. |
| Q57847978 | Activities of cytochrome c oxidase and citrate synthase in lymphocytes of obese and normal-weight subjects |
| Q28210985 | Analysis of microsatellite markers at the UCP2/UCP3 locus on chromosome 11q13 in anorexia nervosa |
| Q84901930 | Association of -55CT polymorphism of UCP3 gene with fat distribution, cardiovascular risk factors and adipocytokines in patients with Type 2 diabetes mellitus |
| Q35830761 | Associations between uncoupling protein 2, body composition, and resting energy expenditure in lean and obese African American, white, and Asian children |
| Q47905398 | Bovine UCP2 and UCP3 map to BTA15. |
| Q37564941 | CKM Gene G (Ncoi-) Allele Has a Positive Effect on Maximal Oxygen Uptake in Caucasian Women Practicing Sports Requiring Aerobic and Anaerobic Exercise Metabolism. |
| Q35711997 | Candidate genes for type 2 diabetes |
| Q57673367 | Characterizing the Extent of Human Genetic Variation for Performance-Related Traits |
| Q33680488 | Contributions of studies on uncoupling proteins to research on metabolic diseases. |
| Q44436458 | Decreased uncoupling protein expression and intramyocytic triglyceride depletion in formerly obese subjects |
| Q37451266 | Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding. |
| Q73884867 | Depot-related and thiazolidinedione-responsive expression of uncoupling protein 2 (UCP2) in human adipocytes |
| Q35050526 | Diet and physical activity in women recovered from anorexia nervosa: a pilot study |
| Q36017740 | Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice |
| Q31514175 | Down-regulation of uncoupling protein-3 and -2 by thiazolidinediones in C2C12 myotubes |
| Q43819481 | Effect of acute exercise on uncoupling protein 3 is a fat metabolism-mediated effect |
| Q24564520 | Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes |
| Q47268591 | Effects of obesity and stable weight reduction on UCP2 and UCP3 gene expression in humans |
| Q73318457 | Endogenous mutations in human uncoupling protein 3 alter its functional properties |
| Q51556110 | Exercise attenuates the fasting-induced transcriptional activation of metabolic genes in skeletal muscle. |
| Q73228428 | Frequency of and interaction between polymorphisms in the beta3-adrenergic receptor and in uncoupling proteins 1 and 2 and obesity in Germans |
| Q34117841 | Further support to the uncoupling-to-survive theory: the genetic variation of human UCP genes is associated with longevity |
| Q43771731 | Genetic variation at the uncoupling protein 1, 2 and 3 loci and the response to long-term overfeeding. |
| Q33680502 | Genetics of human obesity: lessons from mouse models and candidate genes |
| Q48441285 | Genome-wide scan revealed genetic loci for energy metabolism in Hispanic children and adolescents |
| Q42468865 | Genomic organization and mutational analysis of the human UCP2 gene, a prime candidate gene for human obesity |
| Q34175405 | Homologues of the uncoupling protein from brown adipose tissue (UCP1): UCP2, UCP3, BMCP1 and UCP4. |
| Q79713987 | Human uncoupling protein 2 and 3 genes are associated with obesity in Japanese |
| Q43744117 | Hyperlipemia: a role in regulating UCP3 gene expression in skeletal muscle during cancer cachexia? |
| Q34607065 | Identification of quantitative trait loci influencing traits related to energy balance in selection and inbred lines of mice |
| Q34875159 | Increased uncoupling protein 3 content does not affect mitochondrial function in human skeletal muscle in vivo |
| Q40603241 | Increased uncoupling protein-2 gene expression in brain of lipopolysaccharide-injected mice: role of tumour necrosis factor-alpha? |
| Q34502149 | Increasing Obesity in Treated Female HIV Patients from Sub-Saharan Africa: Potential Causes and Possible Targets for Intervention |
| Q72990030 | Induction of uncoupling protein (UCP) 2 in primary cultured hepatocytes |
| Q46592658 | Influence of -55CT polymorphism of UCP3 gene on surgical results of biliopancreatic diversion |
| Q47389934 | Influence of size at birth on the endocrine profiles and expression of uncoupling proteins in subcutaneous adipose tissue, lung, and muscle of neonatal pigs |
| Q54105933 | Insulin resistance, impaired glucose tolerance and non-insulin-dependent diabetes, pathologic mechanisms and treatment: current status and therapeutic possibilities. |
| Q37162265 | Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins |
| Q51559863 | Lack of skeletal muscle uncoupling protein 2 and 3 mRNA induction during fasting in type-2 diabetic subjects. |
| Q43410619 | Linkage and association analyses of the UCP3 gene with obesity phenotypes in Caucasian families |
| Q74200439 | Linkage exclusion analysis of the chromosome 11 region containing UCP2 and UCP3 with obesity-related phenotypes in Mexican Americans |
| Q80141589 | Mitochondrial myopathy complicated by eating disorder: a case report highlighting the potential interaction of genetic, metabolic, and psychodynamic factors |
| Q34083602 | Mitochondrial uncoupling proteins: from mitochondria to the regulation of energy balance |
| Q46619911 | Muscle unloading-induced metabolic remodeling is associated with acute alterations in PPARdelta and UCP-3 expression. |
| Q40615223 | Mutational analysis of the UCP2 core promoter and relationships of variants with obesity |
| Q34743295 | Obesity therapy: altering the energy intake-and-expenditure balance sheet |
| Q35614710 | Physical activity and resting metabolic rate. |
| Q48045384 | Pleiotropic effects of UCP2-UCP3 variability on leucocyte telomere length and glucose homeostasis. |
| Q33993650 | Promising new approaches to the management of obesity |
| Q53880259 | Quantitative trait loci for abdominal fat and BMI in Hispanic-Americans and African-Americans: the IRAS Family study. |
| Q84587504 | Relationship of -55C/T polymorphism of uncoupling protein 3 (UCP3) gene with metabolic syndrome by ATP III classification |
| Q39137151 | Single nucleotide polymorphisms linked to mitochondrial uncoupling protein genes UCP2 and UCP3 affect mitochondrial metabolism and healthy aging in female nonagenarians |
| Q28137660 | Structural organization and mutational analysis of the human uncoupling protein-2 (hUCP2) gene |
| Q57316399 | The Human Obesity Gene Map: The 2004 Update |
| Q90568430 | The Impact of Time of Day on Energy Expenditure: Implications for Long-Term Energy Balance |
| Q73799823 | The association between the val/ala-55 polymorphism of the uncoupling protein 2 gene and exercise efficiency |
| Q55162985 | The effect of mild cold exposure on UCP3 mRNA expression and UCP3 protein content in humans |
| Q41732076 | The human obesity gene map: the 1997 update |
| Q33534349 | The human obesity gene map: the 1998 update |
| Q33839687 | The human obesity gene map: the 1999 update. |
| Q34227908 | The human obesity gene map: the 2000 update |
| Q34557274 | The human obesity gene map: the 2001 update |
| Q35084465 | The human obesity gene map: the 2002 update |
| Q35715184 | The human obesity gene map: the 2003 update |
| Q34567973 | The human obesity gene map: the 2005 update |
| Q78148437 | The long isoform uncoupling protein-3 (UCP3L) in human energy homeostasis |
| Q33800673 | The mitochondrial uncoupling protein-2: current status |
| Q35178608 | The role of uncoupling proteins in the regulation of metabolism |
| Q34741897 | The sympathetic nervous system and obesity: role in aetiology and treatment |
| Q24531899 | The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP |
| Q28144527 | The uncoupling protein-3 gene is transcribed from tissue-specific promoters in humans but not in rodents |
| Q34817393 | Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis |
| Q34635439 | Thyroid hormones in the pathogenesis and treatment of obesity |
| Q51471333 | UCP2 A55V variant is associated with obesity and related phenotypes in an aboriginal community in Taiwan. |
| Q60472332 | UCP2 muscle gene transfer modifies mitochondrial membrane potential |
| Q22008783 | UCP4, a novel brain-specific mitochondrial protein that reduces membrane potential in mammalian cells |
| Q47401204 | Ucp3 expression during weight gain and loss, cold exposure, and fasting in the collared lemming |
| Q51672678 | Uncoupling protein 1 and 3 polymorphisms are associated with waist-to-hip ratio. |
| Q35614715 | Uncoupling protein 3 and physical activity: the role of uncoupling protein 3 in energy metabolism revisited |
| Q44547298 | Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion |
| Q37065665 | Uncoupling proteins: role in insulin resistance and insulin insufficiency |
| Q44576005 | Upregulation of uncoupling proteins by oral administration of capsiate, a nonpungent capsaicin analog |
| Q74243280 | [Genetic studies of obesity in humans] |
| Q52372230 | [Obesity studies in candidate genes]. |